Amylyx Pharmaceuticals, Inc. (AMLX)
14.01
-0.01
(-0.07%)
USD |
NASDAQ |
Feb 20, 16:00
14.01
0.00 (0.00%)
After-Hours: 20:00
Amylyx Pharmaceuticals Total Liabilities (Quarterly) : 30.74M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Biogen, Inc. | 11.18B |
| Cytokinetics, Inc. | 1.958B |
| Ionis Pharmaceuticals, Inc. | 2.415B |
| MediciNova, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 413.50M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 362.74M |
| Shareholders Equity (Quarterly) | 332.00M |
| Debt to Equity Ratio | 0.0179 |
| Current Ratio | 13.70 |
| Net Debt Paydown Yield | -0.04% |